BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bakke I, Qvigstad G, Brenna E, Sandvik AK, Waldum HL. Gastrin has a specific proliferative effect on the rat enterochromaffin-like cell, but not on the parietal cell: a study by elutriation centrifugation. Acta Physiol Scand. 2000;169:29-37. [PMID: 10759608 DOI: 10.1046/j.1365-201x.2000.00688.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Fossmark R, Rao S, Mjønes P, Munkvold B, Flatberg A, Varro A, Thommesen L, Nørsett KG. PAI-1 deficiency increases the trophic effects of hypergastrinemia in the gastric corpus mucosa. Peptides 2016;79:83-94. [PMID: 27038741 DOI: 10.1016/j.peptides.2016.03.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
2 Waldum HL, Hauso Ø, Fossmark R. The regulation of gastric acid secretion - clinical perspectives. Acta Physiol (Oxf). 2014;210:239-256. [PMID: 24279703 DOI: 10.1111/apha.12208] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
3 Sagatun L, Jianu CS, Fossmark R, Mårvik R, Nordrum IS, Waldum HL. The gastric mucosa 25 years after proximal gastric vagotomy. Scandinavian Journal of Gastroenterology 2014;49:1173-80. [DOI: 10.3109/00365521.2014.950979] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Kopic S, Geibel JP. Gastric acid, calcium absorption, and their impact on bone health. Physiol Rev 2013;93:189-268. [PMID: 23303909 DOI: 10.1152/physrev.00015.2012] [Cited by in Crossref: 87] [Cited by in F6Publishing: 58] [Article Influence: 10.9] [Reference Citation Analysis]
5 Bakkelund KE, Waldum HL, Nordrum IS, Hauso Ø, Fossmark R. Long-term gastric changes in achlorhydric H + /K + -ATPase beta subunit deficient mice. Scandinavian Journal of Gastroenterology 2010;45:1042-7. [DOI: 10.3109/00365521.2010.490952] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
6 Gustafsson BI, Bakke I, Hauso Ø, Kidd M, Modlin IM, Fossmark R, Brenna E, Waldum HL. Parietal cell activation by arborization of ECL cell cytoplasmic projections is likely the mechanism for histamine induced secretion of hydrochloric acid. Scand J Gastroenterol 2011;46:531-7. [PMID: 21342027 DOI: 10.3109/00365521.2011.558113] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
7 Sagatun L, Mjønes P, Jianu CS, Boyce M, Waldum HL, Fossmark R. The gastrin receptor antagonist netazepide (YF476) in patients with type 1 gastric enterochromaffin-like cell neuroendocrine tumours: review of long-term treatment. Eur J Gastroenterol Hepatol 2016;28:1345-52. [PMID: 27682220 DOI: 10.1097/MEG.0000000000000713] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
8 Fossmark R, Sørdal Ø, Jianu CS, Qvigstad G, Nordrum IS, Boyce M, Waldum HL. Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A. Aliment Pharmacol Ther 2012;36:1067-75. [DOI: 10.1111/apt.12090] [Cited by in Crossref: 73] [Cited by in F6Publishing: 58] [Article Influence: 8.1] [Reference Citation Analysis]
9 Fjeldbo CS, Bakke I, Erlandsen SE, Holmseth J, Lægreid A, Sandvik AK, Thommesen L, Bruland T. Gastrin upregulates the prosurvival factor secretory clusterin in adenocarcinoma cells and in oxyntic mucosa of hypergastrinemic rats. American Journal of Physiology-Gastrointestinal and Liver Physiology 2012;302:G21-33. [DOI: 10.1152/ajpgi.00197.2011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
10 Cavalcoli F, Zilli A, Conte D, Ciafardini C, Massironi S. Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence? Scand J Gastroenterol. 2015;50:1397-1403. [PMID: 26059834 DOI: 10.3109/00365521.2015.1054426] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
11 Waldum HL. Clinical consequences of controversies in gastric physiology. Scand J Gastroenterol 2020;55:752-8. [PMID: 32515242 DOI: 10.1080/00365521.2020.1771758] [Reference Citation Analysis]
12 Nørsett KG, Laegreid A, Langaas M, Wörlund S, Fossmark R, Waldum HL, Sandvik AK. Molecular characterization of rat gastric mucosal response to potent acid inhibition. Physiol Genomics 2005;22:24-32. [PMID: 15827235 DOI: 10.1152/physiolgenomics.00245.2004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
13 Waldum HL, Kleveland PM, Brenna E, Bakke I, Qvigstad G, Martinsen TC, Fossmark R, Gustafsson BI, Sandvik AK. Interactions between gastric acid secretagogues and the localization of the gastrin receptor. Scandinavian Journal of Gastroenterology 2009;44:390-3. [DOI: 10.1080/00365520802624219] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
14 Waldum H, Fossmark R. Gastritis, Gastric Polyps and Gastric Cancer. Int J Mol Sci 2021;22:6548. [PMID: 34207192 DOI: 10.3390/ijms22126548] [Reference Citation Analysis]
15 Agréus L, Storskrubb T, Aro P, Ronkainen J, Talley NJ, Sipponen P. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population. Scand J Gastroenterol 2009;44:564-70. [PMID: 19263272 DOI: 10.1080/00365520902745062] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
16 Fossmark R, Johnsen G, Johanessen E, Waldum HL. Rebound acid hypersecretion after long-term inhibition of gastric acid secretion. Aliment Pharmacol Ther. 2005;21:149-154. [PMID: 15679764 DOI: 10.1111/j.1365-2036.2004.02271.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 54] [Article Influence: 4.6] [Reference Citation Analysis]
17 Waldum H. Tumor Classification Should Be Based on Biology and Not Consensus: Re-Defining Tumors Based on Biology May Accelerate Progress, An Experience of Gastric Cancer. Cancers (Basel) 2021;13:3159. [PMID: 34202596 DOI: 10.3390/cancers13133159] [Reference Citation Analysis]
18 Grong E, Nord C, Arbo IB, Eriksson M, Kulseng BE, Ahlgren U, Mårvik R. The effect of hypergastrinemia following sleeve gastrectomy and pantoprazole on type 2 diabetes mellitus and beta-cell mass in Goto-Kakizaki rats. J Endocrinol Invest 2018;41:691-701. [PMID: 29168078 DOI: 10.1007/s40618-017-0793-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Waldum HL, Fossmark R. Types of Gastric Carcinomas. Int J Mol Sci. 2018;19. [PMID: 30567376 DOI: 10.3390/ijms19124109] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
20 Qvigstad G, Waldum H. Rebound hypersecretion after inhibition of gastric acid secretion. Basic Clin Pharmacol Toxicol. 2004;94:202-208. [PMID: 15125689 DOI: 10.1111/j.1742-7843.2004.pto940502.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
21 Qvigstad G, Kolbjørnsen Ø, Skancke E, Waldum H. Gastric Neuroendocrine Carcinoma Associated with Atrophic Gastritis in the Norwegian Lundehund. Journal of Comparative Pathology 2008;139:194-201. [DOI: 10.1016/j.jcpa.2008.07.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
22 Koh TJ. Extragastric Effects of Gastrin Gene Knock-Out Mice: EXTRAGASTRIC EFFECTS OF GASTRIN. Pharmacology & Toxicology 2002;91:368-74. [DOI: 10.1034/j.1600-0773.2002.910615.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
23 Grosse J, Meier K, Bauer TJ, Eilles C, Grimm D. Cell separation by countercurrent centrifugal elutriation: recent developments. Prep Biochem Biotechnol 2012;42:217-33. [PMID: 22509848 DOI: 10.1080/10826068.2011.602799] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
24 Schubert ML. Gastric secretion: . Current Opinion in Gastroenterology 2001;17:481-8. [DOI: 10.1097/00001574-200111000-00002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
25 Sato Y. Endoscopic diagnosis and management of type I neuroendocrine tumors. World J Gastrointest Endosc. 2015;7:346-353. [PMID: 25901213 DOI: 10.4253/wjge.v7.i4.346] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
26 Waldum HL, Hauso Ø, Sørdal ØF, Fossmark R. Gastrin May Mediate the Carcinogenic Effect of Helicobacter pylori Infection of the Stomach. Dig Dis Sci 2015;60:1522-7. [DOI: 10.1007/s10620-014-3468-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
27 Sagatun L, Fossmark R, Jianu CS, Qvigstad G, Nordrum IS, Mjønes P, Waldum HL. Follow-up of patients with ECL cell-derived tumours. Scand J Gastroenterol 2016;51:1398-405. [PMID: 27309188 DOI: 10.3109/00365521.2016.1169588] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
28 Erlandsen SE, Fykse V, Waldum HL, Sandvik AK. Octreotide induces apoptosis in the oxyntic mucosa. Molecular and Cellular Endocrinology 2007;264:188-96. [DOI: 10.1016/j.mce.2006.12.031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
29 Mjønes P, Nordrum IS, Sørdal Ø, Sagatun L, Fossmark R, Sandvik A, Waldum HL. Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells. Horm Cancer 2018;9:40-54. [PMID: 28980157 DOI: 10.1007/s12672-017-0311-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
30 Dufresne M, Seva C, Fourmy D. Cholecystokinin and gastrin receptors. Physiol Rev 2006;86:805-47. [PMID: 16816139 DOI: 10.1152/physrev.00014.2005] [Cited by in Crossref: 302] [Cited by in F6Publishing: 247] [Article Influence: 20.1] [Reference Citation Analysis]
31 Jianu CS, Fossmark R, Viset T, Qvigstad G, Sørdal O, Mårvik R, Waldum HL. Gastric carcinoids after long-term use of a proton pump inhibitor. Aliment Pharmacol Ther 2012;36:644-9. [PMID: 22861200 DOI: 10.1111/apt.12012] [Cited by in Crossref: 76] [Cited by in F6Publishing: 60] [Article Influence: 8.4] [Reference Citation Analysis]
32 Schubert ML, Rehfeld JF. Gastric Peptides-Gastrin and Somatostatin. Compr Physiol 2019;10:197-228. [PMID: 31853955 DOI: 10.1002/cphy.c180035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
33 Waldum HL, Kleveland PM, Sandvik AK, Brenna E, Syversen U, Bakke I, Tømmerås K. The cellular localization of the cholecystokinin 2 (gastrin) receptor in the stomach. Pharmacol Toxicol 2002;91:359-62. [PMID: 12688379 DOI: 10.1034/j.1600-0773.2002.910613.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
34 Waldum H, Mjønes PG. Correct Identification of Cell of Origin May Explain Many Aspects of Cancer: The Role of Neuroendocrine Cells as Exemplified from the Stomach. Int J Mol Sci 2020;21:E5751. [PMID: 32796591 DOI: 10.3390/ijms21165751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Waldum HL, Syversen U. Serum chromogranin A in the control of patients on long-term treatment with inhibitors of acid secretion. Eur J Clin Invest. 2001;31:741-743. [PMID: 11589715 DOI: 10.1046/j.1365-2362.2001.00889.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
36 Koh TJ, Chen D. Gastrin as a growth factor in the gastrointestinal tract. Regul Pept. 2000;93:37-44. [PMID: 11033051 DOI: 10.1016/s0167-0115(00)00176-2] [Cited by in Crossref: 73] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
37 Waldum HL, Kleveland PM, Fossmark R. Upper gastrointestinal physiology and diseases. Scand J Gastroenterol 2015;50:649-56. [PMID: 25857514 DOI: 10.3109/00365521.2015.1009157] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
38 Jianu CS, Lange OJ, Viset T, Qvigstad G, Martinsen TC, Fougner R, Kleveland PM, Fossmark R, Hauso Ø, Waldum HL. Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor. Scandinavian Journal of Gastroenterology 2011;47:64-7. [DOI: 10.3109/00365521.2011.627444] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
39 Mazzoni M, Le Gall M, De Filippi S, Minieri L, Trevisi P, Wolinski J, Lalatta-costerbosa G, Lallès J, Guilloteau P, Bosi P. Supplemental Sodium Butyrate Stimulates Different Gastric Cells in Weaned Pigs. The Journal of Nutrition 2008;138:1426-31. [DOI: 10.1093/jn/138.8.1426] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
40 Nørsett KG, Laegreid A, Kusnierczyk W, Langaas M, Ylving S, Fossmark R, Myhre S, Falkmer S, Waldum HL, Sandvik AK. Changes in gene expression of gastric mucosa during therapeutic acid inhibition. Eur J Gastroenterol Hepatol. 2008;20:613-623. [PMID: 18679062 DOI: 10.1097/MEG.0b013e3282f5dc19] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
41 Lerotić I, Baršić N, Stojsavljević S, Duvnjak M. Acid Inhibition and the Acid Rebound Effect. Dig Dis 2011;29:482-6. [DOI: 10.1159/000331514] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
42 Sun FP, Song YG. G and D cells in rat antral mucosa: an immunoelectron microscopic study. World J Gastroenterol 2003;9:2768-71. [PMID: 14669330 DOI: 10.3748/wjg.v9.i12.2768] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
43 Tømmerås K, Bakke I, Sandvik AK, Larsson E, Waldum HL. Rat parietal cells express CCK2 receptor mRNA: gene expression analysis of single cells isolated by laser-assisted microdissection. Biochemical and Biophysical Research Communications 2002;297:335-40. [DOI: 10.1016/s0006-291x(02)02202-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Sandvik AK, Cui G, Bakke I, Munkvold B, Waldum HL. PACAP stimulates gastric acid secretion in the rat by inducing histamine release. American Journal of Physiology-Gastrointestinal and Liver Physiology 2001;281:G997-G1003. [DOI: 10.1152/ajpgi.2001.281.4.g997] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
45 Sørdal Ø, Waldum H, Nordrum IS, Boyce M, Bergh K, Munkvold B, Qvigstad G. The Gastrin Receptor Antagonist Netazepide (YF476) Prevents Oxyntic Mucosal Inflammation Induced by Helicobacter Pylori Infection in Mongolian Gerbils. Helicobacter 2013;18:397-405. [DOI: 10.1111/hel.12066] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
46 McCarthy DM. Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship? Int J Mol Sci 2020;21:E662. [PMID: 31963924 DOI: 10.3390/ijms21020662] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
47 Schubert ML, Peura DA. Control of gastric acid secretion in health and disease. Gastroenterology. 2008;134:1842-1860. [PMID: 18474247 DOI: 10.1053/j.gastro.2008.05.021] [Cited by in Crossref: 269] [Cited by in F6Publishing: 197] [Article Influence: 20.7] [Reference Citation Analysis]
48 Waldum HL, Gustafsson B, Fossmark R, Qvigstad G. Antiulcer drugs and gastric cancer. Dig Dis Sci. 2005;50 Suppl 1:S39-S44. [PMID: 16184420 DOI: 10.1007/s10620-005-2805-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
49 Waldum HL, Martinsen TC, Hauso O, Qvigstad G. Oral proton-pump inhibitors and step-down therapy for nonulcer dyspepsia: is this the right approach? Therap Adv Gastroenterol 2010;3:73-6. [PMID: 21180591 DOI: 10.1177/1756283X09357220] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
50 Waldum HL, Qvigstad G, Fossmark R, Kleveland PM, Sandvik AK. Rebound acid hypersecretion from a physiological, pathophysiological and clinical viewpoint. Scandinavian Journal of Gastroenterology 2010;45:389-94. [DOI: 10.3109/00365520903477348] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]